Nongenomic Steroid Actions: Fact or Fantasy?

Vitamins and Hormones

Volumn 57, Issue C, 1997, Pages 325-373

  Christ, Michael ^a   Haseroth, Karin ^a   Falkenstein, Elisabeth ^a   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MINERALOCORTICOID; STEROID; STEROID RECEPTOR;

ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GONAD; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GONADS; HUMANS; MINERALOCORTICOIDS; RECEPTORS, STEROID; STEROIDS;

EID: 0032601984     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60647-0     Document Type: Article

References (229)

1. Alderson R., Pastan I., and Cheng S. Characterization of the 3,3′,5-triiodo-L-thyronine-binding site on plasma membranes from human placenta. Endocrinology 116 (1985) 2621-2630
2. Al-Dujaili E.A.S., and Edwards C.R.W. The development and application of direct radioimmunoassay for plasma aldosterone using 131-I-labelled ligand-Comparison of three methods. J. Clin. Endocrinol. Metab. 46 (1978) 105-113
3. Allera A., Rao G.S., and Breuer H. Specific interaction of corticosteroids with components of the cell membrane which are involved in the translocation of the hormone into the intravesicular space of purified rat liver plasma membrane vesicles. J. Steroid Biochem. 12 (1980) 259-266
4. Arai K., Tsigos C., Suzuki Y., Irony I., Karl M., Listwak S., and Chrousos G.P. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: A responsiveness test and therapy. J. Clin. Endocrinol. Metab. 79 (1994) 1019-1023
5. Armanini D., Strasser T., and Weber P.C. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am. J. Physiol. 248 (1985) E388-E390
6. Armanini D., Wehling M., Da Dalt L., Zennaro M., Scali U., Keller U., Pratesi C., Mantero F., and Kuhnle U. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities. J. Steroid Biochem. Mol. Biol. 40 (1991) 363-365
7. Aronica M., and Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in phosphorylation state of rat uterine ER by estrogen cAMP and IGF-1. Mol. Endocrinol. 7 (1993) 743-752
8. Aronica M., Katzenellenbogen B.S., and Kraus W.L. Estrogen action via the cAMP signalling pathway: Stimulation of adenylate cyclase and cAMP regulated gene transcription. Proc. Natl. Acad. Sci. USA 91 (1994) 8517-8521
9. Arriza L.A., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 23 (1987) 268-275
10. Baldi E., Krausz C., Luconi M., Bonaccorsi L., Maggi M., and Forti G. Actions of progesterone on human sperm: A model of non-genomic effects on steroids. J. Steroid Biochem. Mol. Biol. 53 (1995) 199-203
11. 3. J. Cell Biochem. 56 (1994) 303-306
12. 3 physiologic role. Proc. Soc. Exp. Biol. Med. 207 (1994) 175-179
13. 3. J. Cell Biochem. 56 (1994) 510-517
14. Barsony J., and Marx S.J. Rapid accumulation of cyclic GMP near activated vitamin D receptors. Proc. Natl. Acad. Sci. USA 88 (1991) 1436-1440
15. Baulieu E.E. Neurosteroids: A new function in the brain. Biol. Cell 71 (1991) 3-10
16. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
17. Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17 (1996) 587-609
18. Beck C.A., Wolfe M., Murphy L.D., and Wiebe J.P. Acute, nongenomic actions of the neuroactive gonadal steroid, 3α-hydroxy-4-pregnen-20-one (3α HP), on FSH release in perifused rat anterior pituitary cells. Endocrine 6 (1997) 221-229
19. Berridge M.J. Inositol triphosphate and calcium signalling. Nature 361 (1993) 315-325
20. Berthois Y., Pourreau-Schneider N., Gandilhon P., Mittre H., Tubiana M., and Martin P.M. Estradiol membrane binding sites of human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems. J. Steroid Biochem. 25 (1986) 963-972
21. Bilefeldt K., Waite L., Abboud F.M., and Conklin J.L. Nongenomic effects of progesterone on human intestinal smooth muscle cells. Am. J. Physiol. 271 (1996) G370-G376
22. Blackmore J.P., and Lattanzio F. Cell surface localization of a novel nongenomic progesterone receptor on the head of human sperm. Biochem. Biophys. Res. Commun. 81 (1991) 331-336
23. Blackmore P.F., Neulen J., Lattanzio F., and Beebe S.J. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J. Biol. Chem. 266 (1991) 655-659
24. Blaustein J.D., Lehman M.N., Turcotte J.C., and Greene G. Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus. Endocrinology 131 (1992) 281-290
25. Blondeau J.P., and Baulieu E.E. Progesterone receptor characterized by photoaffinity labelling in the plasma membrane of Xenopus laevis oocytes. Biochem. J. 219 (1984) 785-792
26. 2+ accumulation in the cichlid fish pituitary in vitro. Proc. Natl. Acad. Sci. USA 88 (1991) 2758-2762
27. Bosse R., Rivest R., and Di Paolo T. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res. Mol. Brain Res. 46 (1997) 343-346
28. 3 regulate chrondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway. J. Cell. Biochem. 66 (1997) 457-470
29. Bression D., Michard M., LeDafniet M., Pagesy P., and Peillon F. Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology. 119 (1986) 1048-1051
30. 125I]iodohistamine) identifies four protein bands in mouse brain membranes. J. Neurochem. 63 (1994) 1434-1438
31. Carver-Ward J.A., Hollanders J.M.C., Jaroud K.A., Einspenner M., Al-Sedairy S.T., and Sheth K.V. Progesterone does not potentiate the acrosome reaction in human spermatozoa: Flow cytometric analysis using CD46 antibody. Hum. Reprod. 11 (1996) 121-126
32. Cato A.C.B., and Weinmann J. Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells. J. Cell Biol. 106 (1988) 2119-2125
33. 2+ mobilization. Circ. Res. 8 (1997) 885-892
34. +-antiport. Hypertension 25 (1995) 117-123
35. Christ M., Eisen C., Aktas J., Theisen K., and Wehling M. The inositol-1,4,5-trisphosphate system is involved in rapid nongenomic effects of aldosterone in human mononuclear leukocytes. J. Clin. Endocrinol. Metab. 77 (1993) 1452-1457
36. Christ M., Eisen C., Meyer C., Theisen K., and Wehling M. Immediate effects of aldosterone on diacylglycerol production and protein kinase C translocation in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 213 (1995) 123-129
37. Christ M., Sippel K., Eisen C., and Wehling M. Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol. Cell. Endocrinol. 99 (1994) R31-R34
38. Christ M., and Wehling M. Cardiovascular steroid actions: Swift swallows or sluggish snails?. Cardiovasc. Res. 40 (1998) 34-44
39. Clarke R., van den Berg H.W., and Murphy R.F. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17β-estradiol. J. Natl. Cancer Inst. 82 (1990) 1702-1705
40. Costarella C.E., Stallone J.N., Rutecki G.W., and Whittier F.C. Testosterone causes direct relaxation of rat thoracic aorta. J. Pharmacol. Exp. Ther. 277 (1996) 34-39
41. 2+-ATPase activity. J. Clin. Invest. 71 (1983) 579-586
42. DeBold J.F., and Frye C.A. Genomic and non-genomic actions of progesterone in the control of female hamster sexual behaviour. Horm. Behav. 28 (1994) 445-453
43. Disshon K.A., and Dluzen D.E. Estrogen as a neuromodulator of MPTP-induced neurotoxicity: Effects upon stritial dopamine release. Brain Res. 764 (1997) 9-16
44. Doolan C.M., and Harvey B.J. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J. Biol. Chem. 271 (1996) 8763-8767
45. Doolan C.M., and Harvey B.J. Rapid effects of steroid hormones on free intracellular calcium in T84 colonic epithelial cells. Am. J. Physiol. 271 (1996) C1935-C1941
46. 3:Analogs are able to functionally differentiate between nuclear and membrane receptors. Biochem. Biophys. Res. Commun. 201 (1994) 394-401
47. Dudley Jr. S.C., and Baumgarten C.M. Bursting of cardiac sodium channels after acute exposure to 3,5,3′-triiodo-L-thyronine. Circ. Res. 73 (1993) 301-313
48. Dufy B., Vincent J.D., Fleury H., Du-Pasquier P., Gourdji D., and Tixier-Vidal A. Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells. Science 204 (1979) 509-511
49. Edelman I.S., and Fimognari G.M. Modes of hormone action: On the biochemical mechanism of action of aldosterone. Recent Prog. Horm. Res. 24 (1968) 1-44
50. Edwards C.R.W., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutano W.S., de Kloet E.R., and Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet II (1988) 986-989
51. Edwardson J.A., and Bennett G.W. Modulation of corticotrophin-releasing factor release from hypothalamic synaptosomes. Nature 251 (1974) 425-427
52. Eisen C., Meyer C., and Wehling M. Characterization of progesterone membrane binding sites from porcine liver probed with a novel azido-progesterone radioligand. Cell. Mol. Biol. 43 (1997) 165-173
53. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
54. Falkenstein E., Meyer C., Eisen C., Scriba P.C., and Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 229 (1996) 86-89
55. 3 signal response pathways in osteoblasts: Cross-talk between genomic and membrane-initiated pathways. Am. J. Kidney Dis. 31 (1998) 729-742
56. Farhat M.Y., Abiyounes S., Dingaan B., Vargas R., and Ramwell P.W. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J. Pharmacol. Exp. Ther. 276 (1996) 652-657
57. Fiorelli G., Gori F., Frediani U., Franceschelli F., Tanini A., Tosti-Guerra C., Benvenuti S., Gennari L., Becheri L., and Brandi M.L. Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells. Steroid Biochem. Mol. Biol. 59 (1996) 233-240
58. Foresta C., Rossato M., and Virgilio F. Differential modulation by protein kinase C of progesterone-activated responses in human sperm. Biochem. Biophys. Res. Commun. 206 (1995) 408-413
59. 3H-aldosterone to adrenalectomized rat kidney plasma membranes. Life Sci. 11 (1972) 461-473
60. A receptor complex, attenuate pain sensitivity in rats. Brain Res. 643 (1994) 194-203
61. Fuller P.J. The steroid receptor superfamily: Mechanisms of diversity. FASEB J. 5 (1991) 3092-3099
62. Funder J.W. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 259 (1993) 1132-1136
63. Funder J.W. Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance. Annu. Rev. Med. 48 (1997) 231-240
64. Gamarra F., Simic-Schleicher G., Huber R.M., Ulsenheimer A., Scriba P.C., Kuhnle U., and Wehling M. Impaired rapid mineralocorticoid action on free intracellular calcium in pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 82 (1997) 831-834
65. Gametchu B. Glucocorticoid receptor-like antigen in lymphoma cell membranes: Correlation to cell lysis. Science 236 (1987) 456-461
66. Gametchu B., Watson C.S., and Pasko D. Size and steroid-binding characterization of membrane-associated glucocorticoid receptor in S-49 lymphoma cells. Steroids 56 (1991) 402-410
67. Gametchu B., Watson C.S., and Wu S. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J. 7 (1993) 1283-1292
68. Garty H., and Palmer L.G. Epithelial sodium channels: Function, structure, and regulation. Physiol. Rev. 77 (1997) 359-396
69. 2+ and stimulation of a plasma membrane proton conductance. Proc. Natl. Acad. Sci. USA 93 (1996) 10500-10504
70. Gekle M., Silbernagl S., and Oberleithner H. The mineralocorticoid aldosterone activates a proton conductance in cultured kidney cells. Am. J. Physiol. 273 (1997) C1673-C1678
71. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., and Cannon III R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation 90 (1994) 786-791
72. Gilligan D.M., Quyyumi A.A., and Cannon III R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89 (1994) 2545-2551
73. Gorczynska E., and Handelsman D.J. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 136 (1995) 2052-2059
74. Grazzini E., Guillon G., Mouillac B., and Zingg H.H. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392 (1998) 509-512
75. 3 with low affinity for the vitamin D receptor modulate chrondrocytes via membrane effects that are dependent on cell maturation. J. Cell. Physiol. 171 (1997) 357-367
76. Groner B., Hynes N.E., Rahmsdorf J., and Ponta H. Transcription initiation of transfected mouse mammary tumor virus LTR DNA is regulated by glucocorticoid hormones. Nucleic Acids Res. 11 (1983) 4713-4725
77. Gu Q., and Moss R.L. 17β-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. Neuroscience 16 (1996) 3620-3629
78. Hamilton M.A., Stevenson L.W., Fonarow G.C., Steimle A., Goldhaber J.I., Child J.S., Chopra I.J., Moriguchi J.D., and Hage A. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am. J. Cardiol. 81 (1998) 443-447
79. Hammerschmidt D.E., Knabe A.C., Silberstein P.T., Lamche H.R., and Coppo P.A. Inhibition of granulocyte function by steroids is not limited to corticoids. Studies with sex steroids. Inflammation 12 (1988) 277-284
80. 2 in porcine coronary artery. Circulation 91 (1995) 2619-2626
81. Hashimoto M., Inoue S., Muramatsu M., and Masliah E. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro: A possible nongenomic action. Biochem. Biophys. Res. Commun. 240 (1997) 464-470
82. Hendry L.B. Stereochemical complementary of DNA and steroid agonists and antagonists. J. Steroid Biochem. 31 (1988) 493-523
83. Hendry L.B., Witham F.H., and Chapman O.L. Gene regulation: The involvement of stereochemical recognition in DNA-small molecule interactions. Perspect. Biol. Med. 21 (1977) 120-130
84. Hua S.Y., and Chen Y.Z. Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 124 (1989) 687-691
85. Hummerich H., and Soboll S. Rapid stimulation of calcium uptake into rat liver by L-tri-iodothyronine. Biochem. J. 258 (1989) 363-367
86. Inagaki N., Miura T., Nakajima T., Yoshida K., Nagai H., and Koda A. Studies on the anti-allergic mechanism of glucocorticoids in mice. J. Pharmacobiodyn. 15 (1992) 581-587
87. Joels M., and de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43 (1994) 1-36
88. Joels M., and Karst H. Effects of estradiol and progesterone on voltage-gated calcium and potassium conductances in rat CA1 hippocampal neurons. J. Neurosci. 15 (1995) 4289-4297
89. Kay V.J., Coutts D.R., and Robertson L. Effects of pentoxifylline and progesterone on human sperm capacitation and acrosome reaction. Hum. Reprod. 9 (1994) 2318-2323
90. 125I-bovine serum albumin as a ligand. J. Neurochem. 54 (1990) 467-472
91. Kelly M.J., Moss R.L., Dudley C.A., and Fawcett C.P. The specificity of the response of preoptic-septal area neurons to estrogen: 17α-Estradiol versus 17β-estradiol and the response of extrahypothalamic neurons. Exp. Brain Res. 30 (1977) 52-53
92. 2+ influx-dependent nongenomic pathways. J. Nutr. 125 (1995) 1699S-1703S
93. 1 cells. Mol. Endocrinol. 6 (1992) 120-131
94. Kitazawa T., Hamada E., Kitazawa K., and Gaznabi A.K. Non-genomic mechanism of 17 β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J. Physiol. 499 (1997) 497-511
95. Klein K., and Henk W. Klinisch-experimentelle Untersuchungen über den Einfluβ von Aldosteron auf Hämodynamik und Gerinnung. Z. Kreisl. Forsch. 52 (1963) 40-53
96. Klemperer J.D., Klein I.L., Ojamaa K., Helm R.E., Gomez M., Isom O.W., and Krieger K.H. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann. Thorac. Surg. 61 (1996) 1323-1327
97. Koch B., Lutz-Bucher B., Briaud B., and Mialhe C. Specific interaction of corticosteroids with binding sites in the plasma membranes of the rat anterior pituitary gland. J. Endocrinol. 79 (1978) 215-222
98. Komesaroff P.A., Verity K., and Fuller P.J. Pseudohypoaldosteronism: Molecular characterization of the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 79 (1994) 27-31
99. Korneyev A., Pan B.S., Polo A., Romeo E., Guidotti A., and Costa E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J. Neurochem. 61 (1993) 1515-1524
100. Kostello A.B., Weinstein S.P., and Morelli G.A. Specific binding of progesterone to the cell surface and its role in the meiotic divisions of rana oocytes. Biochim. Biophys. Acta 720 (1982) 356-363
101. Koukouritaki S.B., Theodoropoulos P.A., Margioris A.N., Gravanis A., and Stournaras C. Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: Evidence for nongenomic actions involving cAMP turnover. J. Cell. Biochem. 62 (1996) 251-261
102. Kuhnle U., Hinkel G.K., Akkurt H.I., and Krozowski Z. Familial pseudohypoaldosteronism: A review on the heterogeneity of the syndrome. Steroids 60 (1995) 157-160
103. Lagrange A.H., Ronnekleiv O.K., and Kelly M.J. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol. Pharmacol. 51 (1997) 605-612
104. Lamche H.R., Silberstein P.T., Knabe A.C., Thomas D.D., Jacob H.S., and Hammerschmidt D.E. Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Studies using electron paramagnetic resonance. Inflammation 14 (1990) 61-70
105. Lantin-Hermoso R.L., Rosenfeld C.R., Yuhanna I.S., German Z., Chen Z., and Shaul P.W. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 273 (1997) L119-L126
106. Lieberherr M., and Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J. Biol. Chem. 269 (1994) 7217-7223
107. Lomax R.B., Cobbold P.H., Allshire A.P., Cuthbertson K.S., and Robertson W.R. Tri-iodothyronine increases intra-cellular calcium levels in single rat myocytes. J. Mol. Endocrinol. 7 (1991) 77-79
108. Luconi M., Bonaccorsi L., Maggi M., Pecchioli P., Krausz C., Forti G., and Baldi E. Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J. Clin. Endocrinol. Metab. 83 (1998) 877-885
109. Machelon V., Nome F., and Tesarik J. Nongenomic effects of androstenedione on human granulosa luteinizing cells. J. Clin. Endocrinol. Metab. 83 (1998) 263-269
110. A receptor. Eur. J. Pharmacol. 189 (1990) 307-315
111. Mandler R.N., Seamer L.C., Domalewski M.D., and Bankhurst A.D. Progesterone but not estrogen depolarizes natural killer cells. Nat. Immun. 12 (1993) 128-135
112. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun. 241 (1997) 419-426
113. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12 (1991) 141-147
114. McNeill A.M., Duckles S.P., and Krause D.N. Relaxant effects of 17β-estradiol in the rat tail artery are greater in females than males. Eur. J. Pharmacol. 308 (1996) 305-309
115. Meiri H. Is synaptic transmission modulated by progesterone?. Brain Res. 385 (1986) 193-196
116. Menachery A., Braley L.M., Kifor I., Gleason R., and Williams G.H. Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats. Am. J. Physiol. 261 (1991) E449-E487
117. Mendoza C., Soler A., and Tesarik J. Nongenomic steroid action: Independent targeting of plasma membrane calcium channel and a tyrosine kinase. Biochem. Biophys. Res. Commun. 210 (1995) 518-523
118. Mermelstein P.G., Becker J.B., and Surmeier D.I. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16 (1996) 595-604
119. Meyer C., Christ M., and Wehling M. Characterization and solubilization of novel aldosterone binding proteins in porcine liver microsomes. Eur. J. Biochem. 229 (1995) 736-740
120. Meyer C., Schmid R., Scriba P.C., and Wehling M. Purification and partial sequencing of high affinity progesterone-binding site(s) from porcine liver membranes. Eur. J. Biochem. 239 (1996) 726-731
121. Moore F.L., and Orchinik M. Membrane receptors for corticosterone: A mechanism for rapid behavioral responses in an amphibian. Horm. Behav. 28 (1994) 512-519
122. Moore F.L., Orchinik M., and Lowry C. Functional studies of corticosterone receptors in neuronal membranes. Receptor 5 (1995) 21-28
123. 3. Biochem. J. 289 (1993) 675-679
124. Morley P., Whitfield J.F., Vanderhyden B.C., Tsang B.K., and Schwartz J.L. A new, nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 131 (1992) 1305-1312
125. + efflux from arterial smooth muscle. Hypertension 6 (1984) 425-430
126. Moyer M.L., Borror K.C., Bona B.J., DeFranco D.B., and Nordeen S.K. Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J. Biol. Chem. 268 (1993) 22933-22940
127. Mueck A.O., Seeger H., and Lippert T.H. Calcium antagonistic effect of natural and synthetic estrogens-Investigations on a nongenomic mechanism of direct vascular action. Int. J. Clin. Pharmacol. Ther. 34 (1996) 424-426
128. Myers J.H., and Bohr D. Mechanisms responsible for the pressure elevation in sodium dependent mineralocorticoid hypertension. In: Mantero F., Biglieri E.G., and Edwards C.R.W. (Eds). "Endocrinology of Hypertension" (1985), Raven Press, New York 131-148
129. Myles A.B., and Daly J.R. "Corticosteroid and ACTH Treatment." (1974), Edward Arnold, London
130. Nakhla A.M., and Rosner W. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 137 (1996) 4126-4129
131. 3: Potential relation of a plasmalemmal receptor to the acute enhancement of intestine calcium transport in chick. J. Nutr. 125 (1995) 1695S-1698S 6 Suppl
132. Nemere I., Zhou L.X., and Norman A.W. Nontranscriptional effects of steroid hormones. Receptor 3 (1993) 277-291
133. 3 in basal lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269 (1994) 23750-23756
134. Nordeen S.K., Bona B.J., and Moyer M.L. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol. Endocrinol. 7 (1993) 731-741
135. Nordeen S.K., Moyer M.L., and Bona B.J. The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology 134 (1994) 1723-1732
136. 3as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. J. Biol. Chem. 268 (1993) 13811-13819
137. + exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc. Natl. Acad. Sci. USA 84 (1987) 1464-1468
138. Oehninger S., Blackmore P., Morshedi M., Acosta A.A., and Alexander N.J. Defective calcium influx and acrosome reaction (spontaneous and progesterone-induced) in spermatozoa of infertile men with severe teratozoospermia. Fertil. Steril. 61 (1994) 349-354
139. Oguchi A., Ikeda U., Kanbe T., Tsuruya Y., Yamamoto K., Kawakami K., Medford R.M., and Shimada K. Regulation of Na-K-ATPase gene expression by aldosterone in vascular smooth muscle cells. Am. J. Physiol. 265 (1993) H1167-H1172
140. Ojamaa K., Klemperer J.D., and Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6 (1996) 505-512
141. O'Malley B.W., Tsai S.Y., Bagchi M., Weigel N.L., Schrader W.T., and Tsai M.J. Molecular mechanism of action of a steroid hormone receptor. Rec. Prog. Horm. Res. 47 (1991) 1-26
142. Orchinik M., Murray T.F., and Moore F.L. A corticosteroid receptor in neuronal membranes. Science 252 (1991) 1848-1851
143. Orchinik M., Murray T.F., Franklin P.H., and Moore F.L. Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc. Natl. Acad. Sci. USA 89 (1992) 3830-3834
144. 3H-aldosterone. Exp. Clin. Endocrinol. 92 (1988) 194-198
145. Pappas T.C., Gametchu B., and Watson C.S. Membrane estrogen receptors identified by multiple anitbody labeling and impeded-ligand binding. FASEB J. 9 (1995) 401-410
146. Park K.W., Dai H.B., Ojamaa K., Lowenstein E., Klein I., and Sellke F.W. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth. Analg. 85 (1997) 734-738
147. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
148. Petrelli M.D., Lim-Tio S.S., Condon J., Hewison M., and Stewart P.M. Differential expression of nuclear 11β-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues. Endocrinology 138 (1997) 3077-3080
149. i is the second messenger for stimulation of apical membrane conductance. J. Clin. Invest. 89 (1992) 150-156
150. Picard D. Steroids tickle cells inside and out. Nature 392 (1998) 437-438
151. Picotto G., Massheimer V., and Boland R. Acute stimulation of intestinal cell calcium influx induced by 17β-estradiol via the cAMP messenger system. Mol. Cell Endocrinol. 119 (1996) 129-134
152. Pietras R.J., and Szego C.M. Endometrial cell calcium and oestrogen action. Nature 253 (1975) 357-359
153. Pietras R.J., and Szego C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265 (1977) 69-72
154. Pliam N.B., and Goldfine I.D. High affinity thyroid hormone binding sites on purified rat liver plasma membranes. Biochem. Biophys. Res. Commun. 79 (1977) 166-172
155. 3H]-Dexamethasone binding to plasma membrane-enriched fractions from liver of nonadrenalectomized rats. Endocrinology 123 (1988) 1642-1651
156. Raddino R., Manca C., Poli E., Bolognesi R., and Visioli O. Effects of 17β-estradiol on the isolated rabbit heart. Arch. Int. Pharmacodyn. 28 (1986) 57-65
157. Ramirez V.D., and Dluzen D. Is progesterone a pre-hormone in the CNS?. J. Steroid Biochem. 27 (1987) 589-598
158. Ramirez V.D., Zheng J., and Siddique K.M. Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: Fantasy or reality?. Cell. Mol. Neurobiol. 16 (1996) 175-198
159. Reddy A.G., Shivaji S., and Gupta P.D. Effect of estradiol on the membrane fluidity of the rat vagina endothelial cells. J. Steroid Biochem. 33 (1989) 1229-1233
160. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G., and Brinker J.A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89 (1994) 52-60
161. Rodriguez Garcia de J., Boto M.J., and Hidalgo A. Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci. 58 (1996) 607-615
162. Roesch D.M., and Keller-Wood M. Progesterone rapidly reduces arterial pressure in ewes. Am. J. Physiol. 272 (1997) H386-H391
163. Rosano C.M., Sarrel P.M., Poole-Wilson P.A., and Collins P. Beneficial effect of oestrogen on exercise induced myocardial ischaemia in women with coronary artery disease. Lancet 342 (1994) 133-136
164. Russell K.S., Caulin-Glaser T., Sessa W.C., and Bender J.R. Estrogen induces rapid signaling events in human endothelial cells which regulates eNOS and MAPK. Circulation 96 (1997) I48 Suppl
165. Sakaguchi Y., Cui G., and Sen L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology 137 (1996) 4744-4751
166. Salas E., Lopez M.G., Villarroya M., Sanchez-Garcia P., De Pascual R., Dixon W.R., and Garcia A.G. Endothelium-independent relaxation by 17α-estradiol of pig coronary arteries. Eur. J. Pharmacol. 258 (1994) 47-55
167. Sato A., Liu J.P., and Funder J.W. Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro. Endocrinology 138 (1997) 3410-3416
168. Schaeffer J.M., Stevens S., Smith R.G., and Hsueh A.J. Binding of 2-hydroxyestradiol to rat anterior pituitary cell membranes. J. Biol. Chem. 255 (1980) 9838-9843
169. Schneider M., Ulsenheimer A., Christ M., and Wehling M. Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells. Am. J. Physiol. 272 (1997) E616-E620
170. Segal J., and Ingbar S.H. An immediate increase in calcium accumulation by rat thymocytes induced by triiodothyronine: Its role in the subsequent metabolic response. Endocrinology 115 (1984) 160-166
171. Selye H. Correlation between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30 (1942) 437-453
172. 3 evokes oscillation of intracellular calcium in pancreatic beta-cell line. Endocrinology 136 (1995) 2852-2861
173. Shaul P.W., Yuhanna I.S., Sherman T.S., German Z., and Chen Z. Role of estrogen receptor alpha in the acute effects of estrogen on endothelial nitric oxide synthase. Circulation 96 (1997) I48 Suppl
174. Shivaji S., and Jagannadham M.V. Steroid-induced pertubation of membranes and its relevance to sperm acrosome reaction. Biochim. Biophys. Acta 1108 (1992) 99-109
175. Somjen D., Kohen F., and Lieberherr M. Nongenomic effects of an anti-idiotypic antibody as an estrogen mimetic in female human and rat osteoblasts. Cell. Biochem. 65 (1997) 53-66
176. Spach C., and Streeten D.H. Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterone, in vitro. J. Clin. Invest. 43 (1964) 217-227
177. Speaker M.G., and Butcher F.R. Cyclic nucleotide fluctuations during steroid induced meiotic maturation of frog oocytes. Nature 267 (1977) 848-850
178. Steiner A., Vogt E., Locher R., and Vetter W. Stimulation of the phosphoinositide signalling system as a possible mechanism for glucocorticoid action in blood pressure control. J. Hypertens. 6 (1988) S366-S368
179. Sudhir K., Chou T.M., Mullen W.L., Hausmann D., Collins P., Yock P.G., and Chatterjee K. Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26 (1995) 807-814
180. Suyemitsu T., and Terayama H. Specific binding sites for natural glucocorticoids in plasma membranes of rat liver. Endocrinology 96 (1975) 1499-1508
181. Tesarik J., and Mendoza C. Nongenomic effects of 17β-estradiol on maturing human oocytes: Relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80 (1995) 1438-1443
182. Tesarik J., Mendoza C., Moos J., and Carreras A. Selective expression of a progesterone receptor on the human sperm surface. Fertil. Steril. 58 (1992) 784-792
183. Tesarik J., Moos J., and Mendoza C. Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm. Endocrinology 133 (1993) 328-335
184. Teschemacher A., Zeise M.L., Holsboer F., and Zieglgänsberger W. The neuroactive steroid 5α-tetrahydrodeoxycorticosterone increases GABAergic postsynaptic inhibition in rat neocortical neurons in vitro. J. Neuroendocrinal. 7 (1995) 233-240
185. Theodoropoulos P.A., Gravanis A., Saridakis I., and Stournaras C. Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors. Cell. Biochem. Funct. 10 (1992) 281-288
186. Thornton S.N., and Nicolaidis S. Long-term mineralocorticoid-induced changes in rat neuron properties plus interaction of aldosterone and ANG II. Am. J. Physiol. 266 (1994) R564-R571
187. Tischkau S.A., and Ramirez V.D. A specific membrane binding protein for progesterone in rat brain: Sex differences and induction by estrogen. Proc. Natl. Acad. Sci. USA 90 (1993) 1285-1289
188. Trueba M., Ibarolla I., Ogiza K., Marino A., and Macarulla J.M. Specific binding sites for corticosterone in isolated cells and plasma membranes from rat liver. J. Membr. Biol. 120 (1991) 115-124
189. Tsai M.J., and O'Malley B.W. "Mechanism of Steroid Hormone Regulation of Gene Transcription." (1994), CRC Press, Boca Raton, FL
190. Uberoi N.K., Hendry L.B., Muldoon T.G., Myers R.B., Segaloff A., Bransome E.D., and Mahesh V.B. Structure-activity relationships of some unique estrogens related to estradiol are predicted by fit into DNA. Steroids 45 (1985) 325-340
191. Ueda I., Tatara T., Chiou J.S., Krishna P.R., and Kamaja H. Structure-selective anaesthetic potency and effects on lipid and protein. Anesth. Analg. 78 (1994) 718-725
192. Vander A.J., Malvin R.L., Wilde W.S., Lapides J., Sullivan L.P., and McMurray V.M. Effects of adrenalectomy and aldosterone on proximal and distal tubular sodium reabsorption. Proc. Soc. Exp. Biol. Med. 99 (1958) 323-325
193. Vargas R., Thomas G., Wroblewska B., and Ramwell P.W. Differential effects of 17α- and 17β-estradiol on PGF2α-mediated contraction in the porcine coronary artery. Adv. Prost. Thromb. Leuk. Res. 19 (1989) 277-280
194. Vassy R., Nicolas P., Yin Y.L., and Perret G.Y. Nongenomic effects of triiodothyronine on cell surface beta-adrenoceptors in cultured embryonic cardiac myocytes. Proc. Soc. Exp. Biol. Med. 214 (1997) 352-358
195. Waldegger S., Beisse F., Apfel H., Breit S., Kolb H.A., Häussinger D., and Lang F. Electrophysical effects of progesterone on hepatocytes. Biochim. Biophys. Acta 1266 (1995) 186-190
196. Walker J.D., Crawford F.A., Kato S., and Spinale F.G. The novel effects of 3,5,3′-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilaated cardiomyopathy. J. Thorac. Cardiovasc. Surg. 108 (1994) 672-679
197. 3) on myocyte contractile processes. Insights into mechanisms of action. J. Thorac. Cardiovasc. Surg. 110 (1995) 1369-1379
198. Wang W., McChain J., and Zucker I. Aldosterone reduces baroceptor discharge in the dog. Hypertension 19 (1992) 270-277
199. 2+]in of Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA 77 (1980) 1534-1536
200. Wehling M. Nongenomic actions of steroid hormones. Trends Endocrinol. Metab. 5 (1994) 347-353
201. Wehling M. Looking beyond the dogma of genomic steroid action: Insights and facts of the 1990s. J. Mol. Med. 73 (1995) 439-447
202. Wehling M. "Genomic and Nongenomic Effects of Aldosterone." (1995), CRC Press, Boca Raton, FL
203. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59 (1997) 365-393
204. Wehling M., Armanini D., Strasser T., and Weber P.C. Effect of aldosterone on the sodium and potassium concentrations in human mononuclear leukocytes. Am. J. Physiol. 252 (1987) E505-E508
205. Wehling M., Kuhnle U., Weber P.C., and Armanini D. Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leukocytes from patients with pseudohypoaldosteronism. Clin. Endocrinol. 28 (1988) 67-74
206. Wehling M., Kuhls S., and Armanini D. Volume regulation of human lymphocytes by aldosterone in isotonic media. Am. J. Physiol. 257 (1989) E170-E174
207. Wehling M., Kuhnle U., Keller U., Weber P.C., and Armanini D. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leukocytes in families with pseudohypoaldosteronism. Clin. Endocrinol. 31 (1989) 597-605
208. Wehling M., Käsmayr J., and Theisen K. Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro. Cell Calcium 11 (1990) 565-571
209. Wehling M., Käsmayr J., and Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: Genomic or nongenomic pathway?. Am. J. Physiol. 260 (1991) E719-E726
210. Wehling M., Christ M., and Theisen K. Membrane receptors for aldosterone: A novel pathway for mineralocorticoid action. Am. J. Physiol. 263 (1992) E974-E979
211. Wehling M., Eisen C., Aktas J., Christ M., and Theisen K. Photoaffinity labeling of plasma membrane receptors for aldosterone from human mononuclear leucocytes. Biochem. Biophys. Res. Commun. 189 (1992) 1424-1428
212. Wehling M., Eisen C., and Christ M. Membrane receptors for aldosterone: A new concept of nongenomic mineralocorticoid action. News Physiol. Sci. 8 (1993) 241-243
213. Wehling M., Ulsenheimer A., Schneider M., Neylon C., and Christ M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: Subcellular localization of calcium release by single cell imaging. Biochem. Biophys. Res. Commun. 204 (1994) 475-481
214. Wehling M., Neylon C.B., Fullerton M., Bobik A., and Funder J.W. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ. Res. 76 (1995) 973-979
215. Wehling M., Bauer M.M., Ulsenheimer A., Schneider M., Neylon C.B., and Christ M. Nongenomic effects of aldosterone on intracellular pH in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 223 (1996) 181-186
216. Wehling M., Spes C.H., Win N., Janson C.P., Schmidt B.M.W., Theisen K., and Christ M. Rapid cardiovascular action of aldosterone in man. J. Clin. Endocrinol. Metab. 83 (1998) 3517-3522
217. White M.M., Zamudio S., Stevens T., Tyler R., Lindenfeld J., Leslie K., and Moore L. Estrogen, progesterone, and vascular reactivity: Potential cellular mechanisms. Endocr. Rev. 16 (1995) 739-751
218. Wiebe J.P. Nongenomic actions of steroids on gonadotropin release. Recent Prog. Horm. Res. 52 (1997) 71-99
219. Willmer E.N. Steroids and cell surfaces. Biol. Rev. 36 (1961) 368-398
220. Yano K., Tsuda Y., Kaji Y., Kanaya S., Fujiino T., and Niho Y. Effects of hydrocortisone on transmembrane currents in guinea pig ventricular myocytes-Possible evidence for positive inotropism. Jpn. Circ. J. 58 (1994) 836-843
221. Yourick D.L., and DeCoster M.A. Acute and chronic effects of estrogenic compounds on glutamate-stimulated phosphatidylinositol metabolism in primary neuronal cultures. Neurosci. Lett. 206 (1996) 145-148
222. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., and Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91 (1994) 1154-1160
223. 3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J. Biol. Chem. 272 (1997) 22617-22622
224. Zange J., Müller K., Gerzer R., Sippel K., and Wehling M. Nongenomic effects of aldosterone on phosphocreatine levels in human calf muscle during recovery from exercise. J. Clin. Endocrinol. Metab. 81 (1996) 4296-4300
225. Zennaro M.C., Borensztein P., Jeunemaitre X., Armanini D., and Soubrier F. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 79 (1994) 32-38
226. 2+ currents in A7r5 vascular smooth muscle cell line. Am. J. Physiol. 266 (1994) C975-C980
227. A receptors in peptidergic nerve terminals. J. Neuroendocrinol. 6 (1994) 533-538
228. Zheng J., Ali A., and Ramirez V.D. Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites. J. Psychiatry Neurosci. 21 (1996) 187-197
229. Zhou Y., Watters J.J., and Dorsa D.M. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137 (1996) 2163-2166